Patent: 9,339,548
✉ Email this page to a colleague
Summary for Patent: 9,339,548
Title: | Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics |
Abstract: | The present invention provides thermo-sensitive, mucoadhesive biopolymer formulations that enhance the penetration of therapeutics across the skin or mucosal surfaces. In a preferred embodiment, the biopolymer formulation comprises co-polymer of poloxamer 188 and propylene glycol, laurocapram and, optionally, one or more therapeutic agents. Also provided are uses of the biopolymer formulations for topical therapy of cancer including cervical cancer. |
Inventor(s): | Hsu; Stephen I-Hong (Gainesville, FL) |
Assignee: | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (Gainesville, FL) |
Application Number: | 14/739,334 |
Patent Claims: | see list of patent claims |
Details for Patent 9,339,548
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | HUMALOG | insulin lispro | Injection | 020563 | 06/14/1996 | ⤷ Try a Trial | 2031-04-01 |
Eli Lilly And Company | HUMALOG | insulin lispro | Injection | 020563 | 08/06/1998 | ⤷ Try a Trial | 2031-04-01 |
Eli Lilly And Company | HUMALOG | insulin lispro | Injection | 020563 | 09/06/2007 | ⤷ Try a Trial | 2031-04-01 |
Eli Lilly And Company | HUMALOG | insulin lispro | Injection | 020563 | 06/06/2017 | ⤷ Try a Trial | 2031-04-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |